The attached is a February 24, 2005 letter signed by 162 experts, asking the World Health Organization to Evaluate New Treaty Framework for Medical Research and Development The proposal for a Medical R&D Treaty (MRDT) was designed as an alternative… Continue Reading
February 16, 2005 109th Congress, 1st Session Issue: Vol. 151, No. 17 — Daily Edition [Pages S1498-S1499] From the Congressional Record Online through the Government Publishing Office [www.gpo.gov] THE DOHA DECLARATION AND THE TRADE PROMOTION AUTHORITY ACT OF 2002 Mr.… Continue Reading
This is a letter, dated July 22, 2004, by six consumer groups, asking Robert Zoellick and other members of the Bush Administration, to change US trade policy, so that research and development, rather than intellectual property rights, were the focus.… Continue Reading
James Love Michael Palmedo Consumer Project on Technology http://www.cptech.org November 28, 2001 Summary According to the US Internal Revenue Service (IRS), US taxpayers received Orphan Drug Tax Credits totaling $80.1 million in fy 1998, and $61.4 million in fy 1997,… Continue Reading
Implementing TRIPS safeguards with particular attention to administrative models for compulsory licensing of patents WHO meeting in Harare, ZimbabweAugust 21, 2001(with additional references to November Doha declaration) James LoveConsumer Project on Technology I. Introduction. TRIPS obligations raise broad public health… Continue Reading
Compulsory Licensing: Models For State Practice In Developing Countries, Access to Medicine and Compliance with the WTO TRIPS Accord Prepared for the United Nations Development Programme January 21, 2001 James Love Consumer Project on Technology http://www.cptech.org Introduction.1 This note addresses… Continue Reading
2000: Paying for health care R&D – Carrots and Sticks James Love* October 19, 2000 *Thirukumaran Balasubramaniam provided research for this paper. Table of Contents Introduction Failures of the Market Investors cannot appropriate all the benefits of research. R&D is… Continue Reading
How much does it cost to develop a new drug? James Love Consumer Project on Technology http://www.cptech.org April 2, 2000 Prepared for the April 2, 2000 meeting of the MSF Working Group on R&D in Geneva. How much does it… Continue Reading
This statement was developed at the Increasing Access to Essential Drugs in a Globalised Economy Working Towards Solutions conference, which was organized by Health Action International, Médecins Sans Frontières, and Consumer Project on Technology, and took place in Amsterdam, the… Continue Reading
Ralph Nader P.O. Box 19312, Washington, DC 20036 James Love Consumer Project on Technology P.O. Box 19367, Washington, DC 20036 http://www.cptech.org Robert Weissman Essential Action P.O. Box 19405, Washington, DC 20036 http://www.essentialaction.org/ September 3, 1999 Dr. Harold E. Varmus Building… Continue Reading